申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP1203769A1
公开(公告)日:2002-05-08
The invention is concerned with a novel hypolipidemic compound, which is of (3R,5R)-3-Butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-5-phenyl-1,4-benzothiazepin-8-ol 1,1-dioxide; or a salt, solvate, or physiologically functional derivative thereof, with processes for its preparation, pharmaceutical compositions containing it and with its use in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions, such as athersclerosis.
这项发明涉及一种新型降脂化合物,即(3R,5R)-3-丁基-3-乙基-2,3,4,5-四氢-7-甲氧基-5-苯基-1,4-苯并噻吩-8-醇-1,1-二氧化物;或其盐、溶剂合物或生理功能衍生物,以及其制备方法、含有它的药物组合物,以及在医学中的应用,特别是在预防和治疗高脂血症等高脂血症状况中的使用。